279 related articles for article (PubMed ID: 38560717)
1. New insights of propolis nanoformulation and its therapeutic potential in human diseases.
Kustiawan PM; Syaifie PH; Al Khairy Siregar KA; Ibadillah D; Mardliyati E
ADMET DMPK; 2024; 12(1):1-26. PubMed ID: 38560717
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
[TBL] [Abstract][Full Text] [Related]
4. Sustainable Applications of Nanopropolis to Combat Foodborne Illnesses.
Bezerra FWF; Silva JME; Fontanari GG; Oliveira JAR; Rai M; Chisté RC; Martins LHDS
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836629
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. From propolis to nanopropolis: An exemplary journey and a paradigm shift of a resinous substance produced by bees.
Javed S; Mangla B; Ahsan W
Phytother Res; 2022 May; 36(5):2016-2041. PubMed ID: 35259776
[TBL] [Abstract][Full Text] [Related]
7. An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.
Hossain S; Yousaf M; Liu Y; Chang D; Zhou X
Front Pharmacol; 2022; 13():876183. PubMed ID: 35444531
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro inhibition effect of propolis on
Taufik FF; Natzir R; Patellongi I; Santoso A; Hatta M; Junita AR; Syukri A; Primaguna MR; Dwiyanti R; Febrianti A
Ann Med Surg (Lond); 2022 Sep; 81():104388. PubMed ID: 36147103
[TBL] [Abstract][Full Text] [Related]
9. Propolis as lipid bioactive nano-carrier for topical nasal drug delivery.
Rassu G; Cossu M; Langasco R; Carta A; Cavalli R; Giunchedi P; Gavini E
Colloids Surf B Biointerfaces; 2015 Dec; 136():908-17. PubMed ID: 26551868
[TBL] [Abstract][Full Text] [Related]
10. Colloidal and vesicular delivery system for herbal bioactive constituents.
Pandey R; Bhairam M; Shukla SS; Gidwani B
Daru; 2021 Dec; 29(2):415-438. PubMed ID: 34327650
[TBL] [Abstract][Full Text] [Related]
11. Herbal and nano-based herbal medicine: New insights into their therapeutic aspects against periodontitis.
Rezaei-Tazangi F; Forutan Mirhosseini A; Fathi A; Roghani-Shahraki H; Arefnezhad R; Vasei F
Avicenna J Phytomed; 2024; 14(4):430-454. PubMed ID: 38952769
[TBL] [Abstract][Full Text] [Related]
12. The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review.
Zulhendri F; Perera CO; Tandean S; Abdulah R; Herman H; Christoper A; Chandrasekaran K; Putra A; Lesmana R
Biomed Pharmacother; 2022 Feb; 146():112595. PubMed ID: 35062065
[TBL] [Abstract][Full Text] [Related]
13. Nanoformulation of Plant-Based Natural Products for Type 2 Diabetes Mellitus: From Formulation Design to Therapeutic Applications.
Wickramasinghe ASD; Kalansuriya P; Attanayake AP
Curr Ther Res Clin Exp; 2022; 96():100672. PubMed ID: 35586563
[TBL] [Abstract][Full Text] [Related]
14. Chemical Variability and Pharmacological Potential of Propolis as a Source for the Development of New Pharmaceutical Products.
Wieczorek PP; Hudz N; Yezerska O; Horčinová-Sedláčková V; Shanaida M; Korytniuk O; Jasicka-Misiak I
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268700
[TBL] [Abstract][Full Text] [Related]
15. Propolis and its therapeutic effects on renal diseases: A review.
Salami F; Mohebbati R; Hosseinian S; Shahraki S; Hossienzadeh H; Khajavi Rad A
Iran J Basic Med Sci; 2024; 27(4):383-390. PubMed ID: 38419887
[TBL] [Abstract][Full Text] [Related]
16. Propolis and its constituents against cardiovascular risk factors including obesity, hypertension, atherosclerosis, diabetes, and dyslipidemia: A comprehensive review.
Khoshandam A; Hedayatian A; Mollazadeh A; Razavi BM; Hosseinzadeh H
Iran J Basic Med Sci; 2023; 26(8):853-871. PubMed ID: 37427329
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxic effect of Brazilian green propolis on human laryngeal epidermoid carcinoma (HEp-2) cells.
Búfalo MC; Candeias JM; Sforcin JM
Evid Based Complement Alternat Med; 2009 Dec; 6(4):483-7. PubMed ID: 18955250
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review.
Anvarifard P; Anbari M; Ostadrahimi A; Ardalan M; Ghoreishi Z
Nutr Metab (Lond); 2022 Jan; 19(1):6. PubMed ID: 35057819
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability enhancers of herbal origin: an overview.
Kesarwani K; Gupta R; Mukerjee A
Asian Pac J Trop Biomed; 2013 Apr; 3(4):253-66. PubMed ID: 23620848
[TBL] [Abstract][Full Text] [Related]
20. Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence.
Zulhendri F; Perera CO; Tandean S
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
